Publicaciones en colaboración con investigadores/as de Commonwealth Scientific and Industrial Research Organisation (2)

2020

  1. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study

    The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 1, pp. 27-35

  2. Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

    The Lancet Diabetes and Endocrinology, Vol. 8, Núm. 7, pp. 606-615